English | 简体中文 | 繁體中文 | 한국어
Share:
Elanders AB: Quarterly Report January - September 2017
January - September
  • Net sales increased by 71 percent to MSEK 6,758 (3,956), of which 5 percentage points were organic.
  • EBITA, not including one-off items, increased to MSEK 297 (254), which was an improvement in the result by 17 percent. Including one-off items EBITA increased to MSEK 269 (245).
  • The operating result, not including one-off items, increased to MSEK 250 (230). Including one-off items the operating result increased to MSEK 222 (221).
  • The result before tax, not including one-off items, was MSEK 191 (210). Including one-off items the result before tax was MSEK 163 (197).
  • The net result was MSEK 120 (138) or SEK 3.41 (4.89) per share.
  • Not including the purchase price of acquisitions, operating cash flow amounted to MSEK -97 (303), and including the purchase price of acquisitions, operating cash flow amounted to MSEK -119 (-1,497), of which MSEK -262 (0) consisted of greater working capital in the form of accounts receivable due to the settlement of a factoring debt during the first quarter. 
  • The increase in net sales is primarily due to the acquisition of LGI, which was consolidated into the Elanders Group at the end of July 2016.
  • The operating result includes one-off items of MSEK -28 (-9) attributable mainly to redundancy costs. 
Third quarter
  • Net sales increased to MSEK 2,355 (1,878), which was an increase of 25 percent, of which 10 percentage points were organic.
  • EBITA, not including one-off items, was MSEK 83 (115). Including one-off items EBITA was MSEK 55 (112).
  • The operating result, not including one-off items, was MSEK 68 (103). Including one-off items the operating result was MSEK 40 (100).
  • The result before tax, not including one-off items, was MSEK 48 (91). Including one-off items the result before tax was MSEK 20 (86).
  • The net result was MSEK 14 (58) or SEK 0.39 (2.04) per share.
  • Not including the purchase price of acquisitions, operating cash flow amounted to MSEK 16 (201), and including acquisitions was MSEK -6 (-1,565).
  • The operating result includes one-off items of MSEK -28 (-3) attributable mainly to redundancy costs.
Further information can be found on Elanders' website www.elanders.com or requested via e-mail [email protected]
Questions concerning this report can be addressed to:
Magnus Nilsson
President and CEO 
Phone: +46 31 750 07 50 
Andréas Wikner
Chief Financial Officer 
Phone: +46 31 750 07 50  
Elanders AB (publ)  
(Company ID 556008-1621) 
P.O. Box 137 
SE-435 23 Mölnlycke, Sweden 
Phone: +46 31 750 00 00 
This information is information that Elanders AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 13:00 CET on 19 October 2017. 




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Elanders AB via Globenewswire

Copyright © Thomson Reuters 2018. All rights reserved.
Press Releases
Lubrizol and Danquinsa Feature High-Performing Bonding Solutions and Non-Yellowing TPUs at Fakuma 2018  
Sept 26, 2018 21:59 ET
INGREDION ANNOUNCES $60 MILLION OF INCREMENTAL PLANNED SPECIALTY CAPITAL INVESTMENTS IN ASIA-PACIFIC; Company's latest move expands its capacity for higher-value specialty ingredients  
Sept 26, 2018 21:29 ET
Lubrizol and Danquinsa Feature High-Performing Bonding Solutions and Non-Yellowing TPUs at Fakuma 2018  
Sept 26, 2018 15:56 ET
Akastor completes sale of 50% of AKOFS Offshore to form Joint Venture with Mitsui and MOL  
Sept 26, 2018 15:37 ET
INGREDION ANNOUNCES $60 MILLION OF INCREMENTAL PLANNED SPECIALTY CAPITAL INVESTMENTS IN ASIA-PACIFIC; Company's latest move expands its capacity for higher-value specialty ingredients  
Sept 26, 2018 15:03 ET
Nomination Committee; Lindab International AB (publ)  
Sept 26, 2018 15:00 ET
Vaisala's Financial Information and Annual General Meeting in 2019  
Sept 26, 2018 12:00 ET
AIR Worldwide Estimates Industry Insured Losses for Typhoon Mangkhut Will be Between USD 1 Billion and USD 2 Billion  
Sept 26, 2018 05:29 ET
FDA Grants Myelo Therapeutics Orphan Drug Designation for Myelo001 as Treatment for Acute Radiation Syndrome  
Sept 25, 2018 17:59 ET
AIR Worldwide Estimates Insured Wind and Storm Surge Losses for Hurricane Florence Will be Between USD 1.7 Billion and USD 4.6 Billion  
Sept 18, 2018 22:04 ET
More News >>
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: